More than nine in 10 executives plan to implement a more robust digital supply chain visibility (SCV) solution over the next 12 months, according to a new report from FourKites.
The Pharmaceutical...
Pfizer and BioNTech recently announced that they will amend the clinical study evaluating the safety, tolerability, and immunogenicity of their COVID-19 vaccine in children.
The Phase 1/2/3 trial...
Moderna recently announced that its COVID-19 vaccine booster increased neutralizing activity levels against the Omicron variant.
The currently authorized 50-microgram booster of mRNA-1273...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently issued positive opinion of Johnson & Johnson’s COVID-19 vaccine booster for...
Johnson & Johnson recently announced preliminary results from an independent study, which showed that a booster shot of its COVID-19 vaccine increased both antibody and T-cell responses.
In the...
The Strategic Advisory Group of Experts on Immunization (SAGE) for the World Health Organization (WHO) recently supported using Johnson & Johnson’s COVID-19 vaccine booster shot in...
Roche and TIB Molbiol recently added three additional research use only test kits to detect mutations present in the Omicron COVID-19 variant.
The three test kits, VirSNip SARS Spike ins214EPE,...
Pfizer and BioNTech recently announced that their COVID-19 vaccine neutralized the SARS-CoV-2 Omicron variant after three doses.
A month after receiving the booster vaccination, sera obtained...
Johnson & Johnson recently announced a potential licensing agreement for its COVID-19 vaccine with Aspen SA Operations (Pty) Ltd, based in South Africa.
The companies will work towards a...
FDA is working with federal partners and regulators to address potential impacts of the new Omicron variant and urges everyone to receive COVID-19 vaccinations or booster shots, according to an...
Johnson & Johnson recently announced that it will evaluate its COVID-19 vaccine against the new and rapidly spreading Omicron variant.
Specifically, Johnson & Johnson is testing blood...
Pfizer and BioNTech recently announced that their COVID-19 vaccine, BNT162b2, was 100 percent effective in adolescents 12 through 15 years of age in a longer-term analysis.
Researchers also...
CDC Director Rochelle Walensky, MD, MPH, recently endorsed the CDC Advisory Committee on Immunization and Practices’ (ACIP’s) recommendation for COVID-19 vaccine booster shots to include...
The US government recently purchased 10 million courses of Pfizer’s COVID-19 antiviral candidate, PAXLOVID.
Under the terms of the agreement, the government will acquire 10 million...
FDA recently expanded the emergency use authorization (EUA) for a booster dose of the Pfizer-BioNTech COVID-19 vaccine to include individuals 18 years of age and older.
Caregivers can administer the...
Pfizer, BioNTech, and instant logistics company, Zipline, collaborated to deliver authorized mRNA COVID-19 vaccines requiring ultra-cold-chain in Ghana.
The companies recently developed and...
Johnson & Johnson recently entered into an agreement with the US government and Gavi, the Vaccine Alliance, to allow access to its single-shot COVID-19 vaccine through the COVAX Humanitarian...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recently recommended the approval of Roche’s COVID-19 antibody combination, Ronapreve.
CHMP...
Merck and Ridgeback Biotherapeutics recently announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) authorized their COVID-19 treatment for adults.
The UK’s...
Pfizer recently announced that its COVID-19 treatment, PAXLOVID, reduced hospitalization and death in high-risk adults with coronavirus by 89 percent compared to placebo.
In the Phase 2/3...
